@article{lamy:hal-04222855,
TITLE = {Switching from natalizumab administration at the day hospital to administration at home. A 1 year prospective study of patient experience and quality of life in 30 consecutive patients with multiple sclerosis (TYSAD-35)},
AUTHOR = {Lamy, Simon and Veillard, David and Doyen, Helene and Kerbrat, Anne and Michel, Laure and Chretien, Emilie and Ousmen, Ahmad and Edan, Giles and Le Page, Emmanuelle},
URL = {https://hal.science/hal-04222855},
JOURNAL = {Multiple Sclerosis and Related Disorders},
PUBLISHER = {Elsevier},
VOLUME = {73},
PAGES = {104657},
YEAR = {2023},
MONTH = May, DOI = {10.1016/j.msard.2023.104657},
KEYWORDS = {Home ; infusion therapy ; Natalizumab ; administration and amp ; dosage ; Patient-centered care ; Patient experience ; Multiple sclerosis ; Quality of life},
PDF = {https://hal.science/hal-04222855/file/Lamy%20et%20al.%20-%202023%20-%20Switching%20from%20natalizumab%20administration%20at%20the%20d.pdf},
HAL_ID = {hal-04222855},
HAL_VERSION = {v1},
}